Appili Therapeutics Inc. – TSX:APLI.TO
Appili Therapeutics stock price today
Appili Therapeutics stock price yearly change
Appili Therapeutics key metrics
Market Cap | 4.24M |
Enterprise value | 8.86M |
P/E | -0.36 |
EV/Sales | N/A |
EV/EBITDA | -1.09 |
Price/Sales | N/A |
Price/Book | -0.90 |
PEG ratio | N/A |
EPS | -0.03 |
Revenue | N/A |
EBITDA | -3.96M |
Income | -3.78M |
Revenue Q/Q | -96.49% |
Revenue Y/Y | 147.59% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAppili Therapeutics stock price history
Appili Therapeutics stock forecast
Appili Therapeutics financial statements
| Jun 2023 | 0 | -1.54M | |
|---|---|---|---|
| Sep 2023 | 337.31K | -976.55K | -289.51% |
| Dec 2023 | 478.39K | -152.33K | -31.84% |
| Mar 2024 | 11.69K | -1.10M | -9433.7% |
| 2026 | 542.96K | -10.72M | -1974.73% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-11-13 | -0.00667 | -0.01 |
|---|
| Jun 2023 | 2170690 | 10.93M | 503.88% |
|---|---|---|---|
| Sep 2023 | 1958106 | 11.65M | 595.21% |
| Dec 2023 | 1968436 | 11.79M | 599.45% |
| Mar 2024 | 1490403 | 12.41M | 833.01% |
| Jun 2023 | -2.02M | -29.71K | 107.57K |
|---|---|---|---|
| Sep 2023 | -237.14K | 0 | 111.72K |
| Dec 2023 | 253.24K | 0 | -45.88K |
| Mar 2024 | -473.72K | 654 | -34.33K |
Appili Therapeutics alternative data
| Aug 2023 | 8 |
|---|---|
| Sep 2023 | 8 |
| Oct 2023 | 8 |
| Nov 2023 | 8 |
| Dec 2023 | 8 |
| Jan 2024 | 8 |
| Feb 2024 | 8 |
| Mar 2024 | 8 |
| Apr 2024 | 8 |
| May 2024 | 8 |
| Jun 2024 | 8 |
| Jul 2024 | 8 |
Appili Therapeutics other data
| Insider | Compensation |
|---|---|
Dr. Armand Balboni J.D., M.D., Ph.D. (1966) Chief Executive Officer & Director | $364,990 |
Dr. Yoav Golan M.S., M.D., MS (1962) Chief Medical Officer | $324,360 |
-
What's the price of Appili Therapeutics stock today?
One share of Appili Therapeutics stock can currently be purchased for approximately $0.12.
-
When is Appili Therapeutics's next earnings date?
Unfortunately, Appili Therapeutics's (APLI.TO) next earnings date is currently unknown.
-
Does Appili Therapeutics pay dividends?
No, Appili Therapeutics does not pay dividends.
-
How much money does Appili Therapeutics make?
Appili Therapeutics has a market capitalization of 4.24M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 40.5% to 827.41K US dollars. Appili Therapeutics made a loss 3.78M US dollars in net income (profit) last year or -$0.01 on an earnings per share basis.
-
What is Appili Therapeutics's stock symbol?
Appili Therapeutics Inc. is traded on the TSX under the ticker symbol "APLI.TO".
-
What is Appili Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Appili Therapeutics?
Shares of Appili Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Appili Therapeutics's key executives?
Appili Therapeutics's management team includes the following people:
- Dr. Armand Balboni J.D., M.D., Ph.D. Chief Executive Officer & Director(age: 59, pay: $364,990)
- Dr. Yoav Golan M.S., M.D., MS Chief Medical Officer(age: 63, pay: $324,360)
-
How many employees does Appili Therapeutics have?
As Jul 2024, Appili Therapeutics employs 8 workers.
-
When Appili Therapeutics went public?
Appili Therapeutics Inc. is publicly traded company for more then 6 years since IPO on 25 Jun 2019.
-
What is Appili Therapeutics's official website?
The official website for Appili Therapeutics is appilitherapeutics.com.
-
Where are Appili Therapeutics's headquarters?
Appili Therapeutics is headquartered at #21-1344 Summer Street, Halifax, NS.
-
How can i contact Appili Therapeutics?
Appili Therapeutics's mailing address is #21-1344 Summer Street, Halifax, NS and company can be reached via phone at +90 24424655.
Appili Therapeutics company profile:
Appili Therapeutics Inc.
appilitherapeutics.comTSX
8
Biotechnology
Healthcare
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Halifax, NS B3H 0A8
:
ISIN: CA03783R1073
:
